Alzheimer's Disease and Mild Cognitive Impairment

Brendan J. Kelley, Ronald C. Petersen

Research output: Contribution to journalReview article

130 Citations (Scopus)

Abstract

As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.

Original languageEnglish (US)
Pages (from-to)577-609
Number of pages33
JournalNeurologic Clinics
Volume25
Issue number3
DOIs
StatePublished - Aug 1 2007

Fingerprint

Alzheimer Disease
Cognition Disorders
Dementia
Public Health
Cognitive Dysfunction

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Alzheimer's Disease and Mild Cognitive Impairment. / Kelley, Brendan J.; Petersen, Ronald C.

In: Neurologic Clinics, Vol. 25, No. 3, 01.08.2007, p. 577-609.

Research output: Contribution to journalReview article

Kelley, Brendan J. ; Petersen, Ronald C. / Alzheimer's Disease and Mild Cognitive Impairment. In: Neurologic Clinics. 2007 ; Vol. 25, No. 3. pp. 577-609.
@article{1087eb0641f84fc299eb3add269de638,
title = "Alzheimer's Disease and Mild Cognitive Impairment",
abstract = "As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.",
author = "Kelley, {Brendan J.} and Petersen, {Ronald C.}",
year = "2007",
month = "8",
day = "1",
doi = "10.1016/j.ncl.2007.03.008",
language = "English (US)",
volume = "25",
pages = "577--609",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Alzheimer's Disease and Mild Cognitive Impairment

AU - Kelley, Brendan J.

AU - Petersen, Ronald C.

PY - 2007/8/1

Y1 - 2007/8/1

N2 - As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.

AB - As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.

UR - http://www.scopus.com/inward/record.url?scp=34447303785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447303785&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2007.03.008

DO - 10.1016/j.ncl.2007.03.008

M3 - Review article

C2 - 17659182

AN - SCOPUS:34447303785

VL - 25

SP - 577

EP - 609

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 3

ER -